BC
Bridgefront Capital’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,832
| Closed | -$267K | – | 649 |
|
|
2025
Q1 | $267K | Sell |
7,832
-9,432
| -55% | -$321K | 0.08% | 431 |
|
|
2024
Q4 | $680K | Buy |
+17,264
| New | +$680K | 0.23% | 134 |
|
|
2024
Q3 | – | Sell |
-4,492
| Closed | -$243K | – | 562 |
|
|
2024
Q2 | $243K | Buy |
+4,492
| New | +$243K | 0.1% | 357 |
|
|
2024
Q1 | – | Sell |
-4,119
| Closed | -$258K | – | 405 |
|
|
2023
Q4 | $258K | Buy |
+4,119
| New | +$258K | 0.19% | 213 |
|
|
2023
Q3 | – | Sell |
-5,387
| Closed | -$302K | – | 431 |
|
|
2023
Q2 | $302K | Buy |
+5,387
| New | +$302K | 0.16% | 242 |
|